Drug Type AAV based gene therapy |
Synonyms K2/P1 gene therapy (Ibex) |
Target- |
Action- |
Mechanism Gene transference |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Sepsis | Preclinical | United States | 19 Jan 2024 |





